Abstract
Objective
To investigate the difference in acute phase protein responses between patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and spondyloarthropathies (SpA).Methods
Circulating levels of cytokines inducing the production of acute phase proteins such as interleukin (IL)-6, IL-1 beta, and tumor necrosis factor (TNF)-alpha, and of cytokine inhibitors such as TNF soluble receptors (TNF-sR55 and TNF-sR75) and IL-1 receptor antagonist (IL-1ra), were measured in 2 cohorts of patients. The first cohort included 52 patients with SLE and 22 with RA, and the second included 21 with SLE, 20 with RA, and 18 with SpA. An examination at the time of blood collection and the Systemic Lupus Activity Measure (SLAM) index were used to assess disease activity in patients with SLE. Serum levels of IL-6 were measured using a biological assay, and concentrations of IL-1 beta, TNF-alpha, TNF-sR55, TNF-sR75, and IL-1ra were assessed by immunoassays.Results
Although C-reactive protein (CRP) levels were significantly lower in SLE than in RA or SpA, the concentrations of circulating IL-6 or TNF-alpha were higher in SLE. The most striking observation was that TNF-sR levels were significantly higher in SLE than in RA or SpA. The TNF-alpha: TNF-sR ratio was also significantly lower in SLE than in RA. TNF-sR55 and TNF-sR75 levels correlated with disease activity in SLE.Conclusion
The weak acute phase protein response in SLE may be explained by a decreased ratio between inducing cytokines and their inhibitors. In addition, TNF-sR may prove a useful biological marker for the followup of SLE, where acute phase protein response is generally low during disease exacerbations.Citations & impact
Impact metrics
Citations of article over time
Article citations
Inflammatory bowel disease pathobiology: the role of the interferon signature.
Ann Gastroenterol, 33(2):125-133, 12 Feb 2020
Cited by: 11 articles | PMID: 32127733 | PMCID: PMC7049232
Review Free to read & use
Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis.
Eye (Lond), 34(9):1614-1623, 05 Dec 2019
Cited by: 3 articles | PMID: 31804623 | PMCID: PMC7608430
Using Multiple Analytical Platforms to Investigate the Androgen Depletion Effects on Fecal Metabolites in a Mouse Model of Systemic Lupus Erythematosus.
J Proteome Res, 19(2):667-676, 27 Dec 2019
Cited by: 1 article | PMID: 31820642 | PMCID: PMC7123809
Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.
Indian J Clin Biochem, 36(1):59-66, 18 Oct 2019
Cited by: 0 articles | PMID: 33505128 | PMCID: PMC7817716
TNF-α promoter polymorphisms (G-238A and G-308A) are associated with susceptibility to Systemic Lupus Erythematosus (SLE) and P. falciparum malaria: a study in malaria endemic area.
Sci Rep, 9(1):11752, 13 Aug 2019
Cited by: 6 articles | PMID: 31409832 | PMCID: PMC6692415
Go to all (135) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Clin Biochem, 38(2):134-141, 01 Feb 2005
Cited by: 27 articles | PMID: 15642275
Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
J Rheumatol, 30(1):28-35, 01 Jan 2003
Cited by: 13 articles | PMID: 12508386
Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
J Rheumatol, 29(5):1071-1078, 01 May 2002
Cited by: 11 articles | PMID: 12022325
[Cytokines and antagonists in septic shock]
Schweiz Med Wochenschr, 123(11):480-491, 01 Mar 1993
Cited by: 3 articles | PMID: 8386392
Review
Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
Kidney Int Suppl, 38:S68-77, 01 Oct 1992
Cited by: 11 articles | PMID: 1328757
Review